Everolimus
These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets for oral use Initial U.S. Approval: 2009
2693c497-a70b-4d00-b6db-602c872e5bed
HUMAN PRESCRIPTION DRUG LABEL
Aug 8, 2022
Ascend Laboratories, LLC
DUNS: 141250469
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Everolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Everolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Everolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Everolimus
Product Details
FDA regulatory identification and product classification information